“…This may be due to the initial up-regulation of a number of signaling molecules in the pathway including MyD88 (5,26). In addition, Nod2 interacts with a number of proteins such as procaspase-1, RIP2, and GRIM-19 (27)(28)(29), which could participate in proinflammatory pathways separate from TLR signaling. In contrast, upon longer MDP pretreatment, we observed increasing self-and cross-tolerance.…”